nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—ABCB1—melanoma	0.12	1	CbGaD
Aripiprazole—CYP3A4—Temozolomide—melanoma	0.0403	0.189	CbGbCtD
Aripiprazole—CYP2D6—Vemurafenib—melanoma	0.0347	0.163	CbGbCtD
Aripiprazole—CYP3A7—Docetaxel—melanoma	0.0259	0.122	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0259	0.122	CbGbCtD
Aripiprazole—ABCB1—Dactinomycin—melanoma	0.0245	0.115	CbGbCtD
Aripiprazole—CYP3A4—Vemurafenib—melanoma	0.0221	0.104	CbGbCtD
Aripiprazole—CYP3A5—Docetaxel—melanoma	0.0194	0.0912	CbGbCtD
Aripiprazole—HTR1D—meninx—melanoma	0.0175	0.188	CbGeAlD
Aripiprazole—DRD5—eyelid—melanoma	0.0158	0.17	CbGeAlD
Aripiprazole—ABCB1—Docetaxel—melanoma	0.0126	0.0594	CbGbCtD
Aripiprazole—CYP3A4—Docetaxel—melanoma	0.00757	0.0356	CbGbCtD
Aripiprazole—CHRM5—skin epidermis—melanoma	0.00444	0.0477	CbGeAlD
Aripiprazole—H1F0—hair follicle—melanoma	0.00273	0.0293	CbGeAlD
Aripiprazole—HTR2A—hindlimb—melanoma	0.00206	0.0222	CbGeAlD
Aripiprazole—HTR1B—blood vessel—melanoma	0.00205	0.022	CbGeAlD
Aripiprazole—HTR1D—blood vessel—melanoma	0.00198	0.0213	CbGeAlD
Aripiprazole—H1F0—neck—melanoma	0.00183	0.0197	CbGeAlD
Aripiprazole—HTR2A—appendage—melanoma	0.00177	0.019	CbGeAlD
Aripiprazole—HTR7—endothelium—melanoma	0.00171	0.0184	CbGeAlD
Aripiprazole—HTR7—blood vessel—melanoma	0.00158	0.017	CbGeAlD
Aripiprazole—CHRM5—eye—melanoma	0.00158	0.017	CbGeAlD
Aripiprazole—CHRM5—skin of body—melanoma	0.00137	0.0148	CbGeAlD
Aripiprazole—H1F0—retina—melanoma	0.00135	0.0145	CbGeAlD
Aripiprazole—HTR1E—head—melanoma	0.00131	0.0141	CbGeAlD
Aripiprazole—H1F0—skin of body—melanoma	0.00119	0.0127	CbGeAlD
Aripiprazole—CHRM4—head—melanoma	0.00115	0.0123	CbGeAlD
Aripiprazole—HTR7—neck—melanoma	0.00113	0.0121	CbGeAlD
Aripiprazole—H1F0—mammalian vulva—melanoma	0.00108	0.0116	CbGeAlD
Aripiprazole—HTR2A—endothelium—melanoma	0.00107	0.0115	CbGeAlD
Aripiprazole—DRD3—head—melanoma	0.00107	0.0115	CbGeAlD
Aripiprazole—HTR1D—eye—melanoma	0.00106	0.0113	CbGeAlD
Aripiprazole—HTR6—head—melanoma	0.00103	0.011	CbGeAlD
Aripiprazole—DRD5—head—melanoma	0.001	0.0107	CbGeAlD
Aripiprazole—HTR2A—blood vessel—melanoma	0.000985	0.0106	CbGeAlD
Aripiprazole—CHRM5—head—melanoma	0.000897	0.00963	CbGeAlD
Aripiprazole—HTR2B—skin of body—melanoma	0.000854	0.00918	CbGeAlD
Aripiprazole—ADRA1B—head—melanoma	0.00082	0.0088	CbGeAlD
Aripiprazole—DRD2—eye—melanoma	0.000795	0.00854	CbGeAlD
Aripiprazole—DRD2—retina—melanoma	0.000788	0.00846	CbGeAlD
Aripiprazole—H1F0—head—melanoma	0.000774	0.00831	CbGeAlD
Aripiprazole—DRD1—head—melanoma	0.000764	0.00821	CbGeAlD
Aripiprazole—HTR3A—head—melanoma	0.000738	0.00792	CbGeAlD
Aripiprazole—HTR2A—neck—melanoma	0.000705	0.00757	CbGeAlD
Aripiprazole—ABCB1—blood vessel—melanoma	0.000646	0.00694	CbGeAlD
Aripiprazole—HRH1—eye—melanoma	0.000628	0.00674	CbGeAlD
Aripiprazole—HTR1B—head—melanoma	0.000619	0.00665	CbGeAlD
Aripiprazole—CHRM2—head—melanoma	0.000616	0.00661	CbGeAlD
Aripiprazole—ADRA2C—mammalian vulva—melanoma	0.000613	0.00659	CbGeAlD
Aripiprazole—HTR1D—head—melanoma	0.000599	0.00644	CbGeAlD
Aripiprazole—HTR2C—head—melanoma	0.000593	0.00637	CbGeAlD
Aripiprazole—ADRB1—head—melanoma	0.000582	0.00626	CbGeAlD
Aripiprazole—SLC6A4—head—melanoma	0.000563	0.00604	CbGeAlD
Aripiprazole—CHRM1—head—melanoma	0.00056	0.00602	CbGeAlD
Aripiprazole—HTR2B—head—melanoma	0.000557	0.00599	CbGeAlD
Aripiprazole—H1F0—lymph node—melanoma	0.000542	0.00582	CbGeAlD
Aripiprazole—HTR2A—eye—melanoma	0.000524	0.00563	CbGeAlD
Aripiprazole—HTR2A—retina—melanoma	0.00052	0.00558	CbGeAlD
Aripiprazole—CHRM3—head—melanoma	0.000502	0.00539	CbGeAlD
Aripiprazole—HTR1A—head—melanoma	0.0005	0.00537	CbGeAlD
Aripiprazole—HRH1—mammalian vulva—melanoma	0.000498	0.00535	CbGeAlD
Aripiprazole—ADRA2A—mammalian vulva—melanoma	0.000489	0.00526	CbGeAlD
Aripiprazole—HTR7—head—melanoma	0.000477	0.00513	CbGeAlD
Aripiprazole—ADRA1A—head—melanoma	0.00046	0.00495	CbGeAlD
Aripiprazole—DRD2—head—melanoma	0.000451	0.00485	CbGeAlD
Aripiprazole—KCNH2—head—melanoma	0.000445	0.00478	CbGeAlD
Aripiprazole—ADRA2C—head—melanoma	0.000439	0.00471	CbGeAlD
Aripiprazole—HTR2B—lymph node—melanoma	0.00039	0.00419	CbGeAlD
Aripiprazole—HRH1—head—melanoma	0.000356	0.00383	CbGeAlD
Aripiprazole—ADRA2A—head—melanoma	0.00035	0.00376	CbGeAlD
Aripiprazole—ABCB1—retina—melanoma	0.000341	0.00366	CbGeAlD
Aripiprazole—KCNH2—lymph node—melanoma	0.000311	0.00334	CbGeAlD
Aripiprazole—ADRA2C—lymph node—melanoma	0.000307	0.0033	CbGeAlD
Aripiprazole—HTR2A—head—melanoma	0.000298	0.0032	CbGeAlD
Aripiprazole—ABCB1—mammalian vulva—melanoma	0.000273	0.00293	CbGeAlD
Aripiprazole—CYP2D6—head—melanoma	0.000271	0.00291	CbGeAlD
Aripiprazole—Dry skin—Docetaxel—melanoma	0.000262	0.000859	CcSEcCtD
Aripiprazole—Chest pain—Bleomycin—melanoma	0.000261	0.000856	CcSEcCtD
Aripiprazole—Myalgia—Bleomycin—melanoma	0.000261	0.000856	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Docetaxel—melanoma	0.000261	0.000855	CcSEcCtD
Aripiprazole—Abdominal pain upper—Docetaxel—melanoma	0.000261	0.000855	CcSEcCtD
Aripiprazole—Rash—Vemurafenib—melanoma	0.00026	0.000854	CcSEcCtD
Aripiprazole—Mental disorder—Temozolomide—melanoma	0.00026	0.000854	CcSEcCtD
Aripiprazole—Dermatitis—Vemurafenib—melanoma	0.00026	0.000853	CcSEcCtD
Aripiprazole—Back pain—Carmustine—melanoma	0.000259	0.000849	CcSEcCtD
Aripiprazole—Headache—Vemurafenib—melanoma	0.000258	0.000849	CcSEcCtD
Aripiprazole—Erythema—Temozolomide—melanoma	0.000258	0.000848	CcSEcCtD
Aripiprazole—Malnutrition—Temozolomide—melanoma	0.000258	0.000848	CcSEcCtD
Aripiprazole—Breast disorder—Docetaxel—melanoma	0.000258	0.000846	CcSEcCtD
Aripiprazole—Discomfort—Bleomycin—melanoma	0.000258	0.000846	CcSEcCtD
Aripiprazole—Malaise—Dactinomycin—melanoma	0.000258	0.000846	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000257	0.000843	CcSEcCtD
Aripiprazole—Cramp muscle—Docetaxel—melanoma	0.000257	0.000843	CcSEcCtD
Aripiprazole—Leukopenia—Dactinomycin—melanoma	0.000256	0.000839	CcSEcCtD
Aripiprazole—Nasopharyngitis—Docetaxel—melanoma	0.000255	0.000838	CcSEcCtD
Aripiprazole—Dysgeusia—Temozolomide—melanoma	0.000253	0.000831	CcSEcCtD
Aripiprazole—Confusional state—Bleomycin—melanoma	0.000252	0.000827	CcSEcCtD
Aripiprazole—Vision blurred—Carmustine—melanoma	0.000252	0.000827	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Docetaxel—melanoma	0.000252	0.000826	CcSEcCtD
Aripiprazole—Tremor—Carmustine—melanoma	0.000251	0.000822	CcSEcCtD
Aripiprazole—Oedema—Bleomycin—melanoma	0.00025	0.000821	CcSEcCtD
Aripiprazole—Anaphylactic shock—Bleomycin—melanoma	0.00025	0.000821	CcSEcCtD
Aripiprazole—Back pain—Temozolomide—melanoma	0.00025	0.00082	CcSEcCtD
Aripiprazole—HRH1—lymph node—melanoma	0.00025	0.00268	CbGeAlD
Aripiprazole—Infection—Bleomycin—melanoma	0.000248	0.000815	CcSEcCtD
Aripiprazole—Anaemia—Carmustine—melanoma	0.000247	0.000811	CcSEcCtD
Aripiprazole—Dysphagia—Docetaxel—melanoma	0.000247	0.00081	CcSEcCtD
Aripiprazole—Agitation—Carmustine—melanoma	0.000246	0.000807	CcSEcCtD
Aripiprazole—ADRA2A—lymph node—melanoma	0.000245	0.00263	CbGeAlD
Aripiprazole—Nausea—Vemurafenib—melanoma	0.000245	0.000805	CcSEcCtD
Aripiprazole—Thrombocytopenia—Bleomycin—melanoma	0.000245	0.000804	CcSEcCtD
Aripiprazole—Vision blurred—Temozolomide—melanoma	0.000244	0.000799	CcSEcCtD
Aripiprazole—Myalgia—Dactinomycin—melanoma	0.000243	0.000798	CcSEcCtD
Aripiprazole—Tremor—Temozolomide—melanoma	0.000242	0.000795	CcSEcCtD
Aripiprazole—Discomfort—Dactinomycin—melanoma	0.00024	0.000789	CcSEcCtD
Aripiprazole—Angina pectoris—Docetaxel—melanoma	0.00024	0.000789	CcSEcCtD
Aripiprazole—Ill-defined disorder—Temozolomide—melanoma	0.00024	0.000787	CcSEcCtD
Aripiprazole—Leukopenia—Carmustine—melanoma	0.000239	0.000786	CcSEcCtD
Aripiprazole—Anaemia—Temozolomide—melanoma	0.000239	0.000784	CcSEcCtD
Aripiprazole—Anorexia—Bleomycin—melanoma	0.000238	0.000782	CcSEcCtD
Aripiprazole—Agitation—Temozolomide—melanoma	0.000237	0.000779	CcSEcCtD
Aripiprazole—Angioedema—Temozolomide—melanoma	0.000236	0.000775	CcSEcCtD
Aripiprazole—Hypotension—Bleomycin—melanoma	0.000234	0.000767	CcSEcCtD
Aripiprazole—Oedema—Dactinomycin—melanoma	0.000233	0.000765	CcSEcCtD
Aripiprazole—Malaise—Temozolomide—melanoma	0.000233	0.000765	CcSEcCtD
Aripiprazole—Vertigo—Temozolomide—melanoma	0.000232	0.000762	CcSEcCtD
Aripiprazole—Convulsion—Carmustine—melanoma	0.000232	0.00076	CcSEcCtD
Aripiprazole—Infection—Dactinomycin—melanoma	0.000232	0.00076	CcSEcCtD
Aripiprazole—Leukopenia—Temozolomide—melanoma	0.000231	0.000759	CcSEcCtD
Aripiprazole—Hypertension—Carmustine—melanoma	0.000231	0.000758	CcSEcCtD
Aripiprazole—Neutropenia—Docetaxel—melanoma	0.000231	0.000757	CcSEcCtD
Aripiprazole—Palpitations—Temozolomide—melanoma	0.000228	0.00075	CcSEcCtD
Aripiprazole—Thrombocytopenia—Dactinomycin—melanoma	0.000228	0.000749	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Bleomycin—melanoma	0.000228	0.000748	CcSEcCtD
Aripiprazole—Chest pain—Carmustine—melanoma	0.000228	0.000747	CcSEcCtD
Aripiprazole—Myalgia—Carmustine—melanoma	0.000228	0.000747	CcSEcCtD
Aripiprazole—Anxiety—Carmustine—melanoma	0.000227	0.000745	CcSEcCtD
Aripiprazole—Cough—Temozolomide—melanoma	0.000225	0.00074	CcSEcCtD
Aripiprazole—Paraesthesia—Bleomycin—melanoma	0.000224	0.000737	CcSEcCtD
Aripiprazole—Weight increased—Docetaxel—melanoma	0.000224	0.000737	CcSEcCtD
Aripiprazole—Convulsion—Temozolomide—melanoma	0.000224	0.000735	CcSEcCtD
Aripiprazole—Weight decreased—Docetaxel—melanoma	0.000223	0.000732	CcSEcCtD
Aripiprazole—Hypertension—Temozolomide—melanoma	0.000223	0.000732	CcSEcCtD
Aripiprazole—Dyspnoea—Bleomycin—melanoma	0.000223	0.000732	CcSEcCtD
Aripiprazole—Anorexia—Dactinomycin—melanoma	0.000222	0.00073	CcSEcCtD
Aripiprazole—Pneumonia—Docetaxel—melanoma	0.000221	0.000726	CcSEcCtD
Aripiprazole—Confusional state—Carmustine—melanoma	0.00022	0.000722	CcSEcCtD
Aripiprazole—Myalgia—Temozolomide—melanoma	0.00022	0.000722	CcSEcCtD
Aripiprazole—Arthralgia—Temozolomide—melanoma	0.00022	0.000722	CcSEcCtD
Aripiprazole—Infestation NOS—Docetaxel—melanoma	0.00022	0.000722	CcSEcCtD
Aripiprazole—Infestation—Docetaxel—melanoma	0.00022	0.000722	CcSEcCtD
Aripiprazole—Anxiety—Temozolomide—melanoma	0.000219	0.00072	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000218	0.000717	CcSEcCtD
Aripiprazole—Oedema—Carmustine—melanoma	0.000218	0.000716	CcSEcCtD
Aripiprazole—Discomfort—Temozolomide—melanoma	0.000217	0.000713	CcSEcCtD
Aripiprazole—Decreased appetite—Bleomycin—melanoma	0.000217	0.000713	CcSEcCtD
Aripiprazole—Infection—Carmustine—melanoma	0.000217	0.000712	CcSEcCtD
Aripiprazole—Acute coronary syndrome—Docetaxel—melanoma	0.000217	0.000712	CcSEcCtD
Aripiprazole—Renal failure—Docetaxel—melanoma	0.000216	0.00071	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Docetaxel—melanoma	0.000216	0.000708	CcSEcCtD
Aripiprazole—Myocardial infarction—Docetaxel—melanoma	0.000216	0.000708	CcSEcCtD
Aripiprazole—Dry mouth—Temozolomide—melanoma	0.000215	0.000706	CcSEcCtD
Aripiprazole—Jaundice—Docetaxel—melanoma	0.000214	0.000704	CcSEcCtD
Aripiprazole—Stomatitis—Docetaxel—melanoma	0.000214	0.000704	CcSEcCtD
Aripiprazole—Pain—Bleomycin—melanoma	0.000214	0.000702	CcSEcCtD
Aripiprazole—Conjunctivitis—Docetaxel—melanoma	0.000214	0.000702	CcSEcCtD
Aripiprazole—Thrombocytopenia—Carmustine—melanoma	0.000214	0.000701	CcSEcCtD
Aripiprazole—Tachycardia—Carmustine—melanoma	0.000213	0.000699	CcSEcCtD
Aripiprazole—Confusional state—Temozolomide—melanoma	0.000213	0.000698	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000212	0.000697	CcSEcCtD
Aripiprazole—Anaphylactic shock—Temozolomide—melanoma	0.000211	0.000692	CcSEcCtD
Aripiprazole—Oedema—Temozolomide—melanoma	0.000211	0.000692	CcSEcCtD
Aripiprazole—Infection—Temozolomide—melanoma	0.000209	0.000688	CcSEcCtD
Aripiprazole—Anorexia—Carmustine—melanoma	0.000208	0.000683	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Docetaxel—melanoma	0.000208	0.000683	CcSEcCtD
Aripiprazole—Epistaxis—Docetaxel—melanoma	0.000207	0.000681	CcSEcCtD
Aripiprazole—Nervous system disorder—Temozolomide—melanoma	0.000207	0.000679	CcSEcCtD
Aripiprazole—Thrombocytopenia—Temozolomide—melanoma	0.000206	0.000678	CcSEcCtD
Aripiprazole—Feeling abnormal—Bleomycin—melanoma	0.000206	0.000676	CcSEcCtD
Aripiprazole—Agranulocytosis—Docetaxel—melanoma	0.000205	0.000674	CcSEcCtD
Aripiprazole—Skin disorder—Temozolomide—melanoma	0.000205	0.000672	CcSEcCtD
Aripiprazole—Hypotension—Carmustine—melanoma	0.000204	0.000669	CcSEcCtD
Aripiprazole—Hyperhidrosis—Temozolomide—melanoma	0.000204	0.000669	CcSEcCtD
Aripiprazole—Decreased appetite—Dactinomycin—melanoma	0.000203	0.000665	CcSEcCtD
Aripiprazole—Fatigue—Dactinomycin—melanoma	0.000201	0.00066	CcSEcCtD
Aripiprazole—Anorexia—Temozolomide—melanoma	0.000201	0.00066	CcSEcCtD
Aripiprazole—Pain—Dactinomycin—melanoma	0.000199	0.000655	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Carmustine—melanoma	0.000199	0.000653	CcSEcCtD
Aripiprazole—Urticaria—Bleomycin—melanoma	0.000199	0.000652	CcSEcCtD
Aripiprazole—Haemoglobin—Docetaxel—melanoma	0.000198	0.000651	CcSEcCtD
Aripiprazole—Rhinitis—Docetaxel—melanoma	0.000198	0.00065	CcSEcCtD
Aripiprazole—Body temperature increased—Bleomycin—melanoma	0.000198	0.000649	CcSEcCtD
Aripiprazole—Hepatitis—Docetaxel—melanoma	0.000197	0.000648	CcSEcCtD
Aripiprazole—Haemorrhage—Docetaxel—melanoma	0.000197	0.000648	CcSEcCtD
Aripiprazole—Insomnia—Carmustine—melanoma	0.000197	0.000648	CcSEcCtD
Aripiprazole—Hypoaesthesia—Docetaxel—melanoma	0.000196	0.000645	CcSEcCtD
Aripiprazole—Paraesthesia—Carmustine—melanoma	0.000196	0.000643	CcSEcCtD
Aripiprazole—Pharyngitis—Docetaxel—melanoma	0.000196	0.000643	CcSEcCtD
Aripiprazole—ABCB1—head—melanoma	0.000195	0.0021	CbGeAlD
Aripiprazole—Urinary tract disorder—Docetaxel—melanoma	0.000195	0.00064	CcSEcCtD
Aripiprazole—Dyspnoea—Carmustine—melanoma	0.000195	0.000639	CcSEcCtD
Aripiprazole—Oedema peripheral—Docetaxel—melanoma	0.000194	0.000638	CcSEcCtD
Aripiprazole—Somnolence—Carmustine—melanoma	0.000194	0.000637	CcSEcCtD
Aripiprazole—Connective tissue disorder—Docetaxel—melanoma	0.000194	0.000637	CcSEcCtD
Aripiprazole—Urethral disorder—Docetaxel—melanoma	0.000193	0.000635	CcSEcCtD
Aripiprazole—Feeling abnormal—Dactinomycin—melanoma	0.000192	0.000631	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Temozolomide—melanoma	0.000192	0.000631	CcSEcCtD
Aripiprazole—Insomnia—Temozolomide—melanoma	0.000191	0.000626	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Dactinomycin—melanoma	0.000191	0.000626	CcSEcCtD
Aripiprazole—Visual impairment—Docetaxel—melanoma	0.00019	0.000624	CcSEcCtD
Aripiprazole—Decreased appetite—Carmustine—melanoma	0.00019	0.000623	CcSEcCtD
Aripiprazole—Paraesthesia—Temozolomide—melanoma	0.000189	0.000622	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Carmustine—melanoma	0.000188	0.000618	CcSEcCtD
Aripiprazole—Dyspnoea—Temozolomide—melanoma	0.000188	0.000617	CcSEcCtD
Aripiprazole—Somnolence—Temozolomide—melanoma	0.000187	0.000615	CcSEcCtD
Aripiprazole—Pain—Carmustine—melanoma	0.000187	0.000613	CcSEcCtD
Aripiprazole—Constipation—Carmustine—melanoma	0.000187	0.000613	CcSEcCtD
Aripiprazole—Dyspepsia—Temozolomide—melanoma	0.000186	0.000609	CcSEcCtD
Aripiprazole—Eye disorder—Docetaxel—melanoma	0.000184	0.000606	CcSEcCtD
Aripiprazole—Abdominal pain—Dactinomycin—melanoma	0.000184	0.000605	CcSEcCtD
Aripiprazole—Body temperature increased—Dactinomycin—melanoma	0.000184	0.000605	CcSEcCtD
Aripiprazole—Hypersensitivity—Bleomycin—melanoma	0.000184	0.000605	CcSEcCtD
Aripiprazole—Decreased appetite—Temozolomide—melanoma	0.000183	0.000602	CcSEcCtD
Aripiprazole—Cardiac disorder—Docetaxel—melanoma	0.000183	0.000601	CcSEcCtD
Aripiprazole—Flushing—Docetaxel—melanoma	0.000183	0.000601	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Temozolomide—melanoma	0.000182	0.000598	CcSEcCtD
Aripiprazole—Fatigue—Temozolomide—melanoma	0.000182	0.000597	CcSEcCtD
Aripiprazole—Pain—Temozolomide—melanoma	0.00018	0.000592	CcSEcCtD
Aripiprazole—Constipation—Temozolomide—melanoma	0.00018	0.000592	CcSEcCtD
Aripiprazole—Feeling abnormal—Carmustine—melanoma	0.00018	0.00059	CcSEcCtD
Aripiprazole—Asthenia—Bleomycin—melanoma	0.000179	0.000589	CcSEcCtD
Aripiprazole—Angiopathy—Docetaxel—melanoma	0.000179	0.000588	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Carmustine—melanoma	0.000178	0.000586	CcSEcCtD
Aripiprazole—Immune system disorder—Docetaxel—melanoma	0.000178	0.000585	CcSEcCtD
Aripiprazole—Mediastinal disorder—Docetaxel—melanoma	0.000178	0.000584	CcSEcCtD
Aripiprazole—Chills—Docetaxel—melanoma	0.000177	0.000581	CcSEcCtD
Aripiprazole—Pruritus—Bleomycin—melanoma	0.000177	0.000581	CcSEcCtD
Aripiprazole—Alopecia—Docetaxel—melanoma	0.000174	0.000573	CcSEcCtD
Aripiprazole—Feeling abnormal—Temozolomide—melanoma	0.000174	0.00057	CcSEcCtD
Aripiprazole—Mental disorder—Docetaxel—melanoma	0.000173	0.000568	CcSEcCtD
Aripiprazole—Abdominal pain—Carmustine—melanoma	0.000172	0.000566	CcSEcCtD
Aripiprazole—Body temperature increased—Carmustine—melanoma	0.000172	0.000566	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Temozolomide—melanoma	0.000172	0.000566	CcSEcCtD
Aripiprazole—Erythema—Docetaxel—melanoma	0.000172	0.000564	CcSEcCtD
Aripiprazole—Malnutrition—Docetaxel—melanoma	0.000172	0.000564	CcSEcCtD
Aripiprazole—Hypersensitivity—Dactinomycin—melanoma	0.000172	0.000564	CcSEcCtD
Aripiprazole—Dysgeusia—Docetaxel—melanoma	0.000168	0.000552	CcSEcCtD
Aripiprazole—Urticaria—Temozolomide—melanoma	0.000168	0.00055	CcSEcCtD
Aripiprazole—Asthenia—Dactinomycin—melanoma	0.000167	0.000549	CcSEcCtD
Aripiprazole—Abdominal pain—Temozolomide—melanoma	0.000167	0.000547	CcSEcCtD
Aripiprazole—Body temperature increased—Temozolomide—melanoma	0.000167	0.000547	CcSEcCtD
Aripiprazole—Back pain—Docetaxel—melanoma	0.000166	0.000546	CcSEcCtD
Aripiprazole—Muscle spasms—Docetaxel—melanoma	0.000165	0.000542	CcSEcCtD
Aripiprazole—Hypersensitivity—Carmustine—melanoma	0.000161	0.000528	CcSEcCtD
Aripiprazole—Diarrhoea—Dactinomycin—melanoma	0.00016	0.000524	CcSEcCtD
Aripiprazole—Vomiting—Bleomycin—melanoma	0.000159	0.000522	CcSEcCtD
Aripiprazole—Anaemia—Docetaxel—melanoma	0.000159	0.000521	CcSEcCtD
Aripiprazole—Rash—Bleomycin—melanoma	0.000158	0.000517	CcSEcCtD
Aripiprazole—Dermatitis—Bleomycin—melanoma	0.000157	0.000517	CcSEcCtD
Aripiprazole—Asthenia—Carmustine—melanoma	0.000157	0.000514	CcSEcCtD
Aripiprazole—Hypersensitivity—Temozolomide—melanoma	0.000155	0.00051	CcSEcCtD
Aripiprazole—Syncope—Docetaxel—melanoma	0.000154	0.000506	CcSEcCtD
Aripiprazole—Leukopenia—Docetaxel—melanoma	0.000154	0.000505	CcSEcCtD
Aripiprazole—Palpitations—Docetaxel—melanoma	0.000152	0.000498	CcSEcCtD
Aripiprazole—Asthenia—Temozolomide—melanoma	0.000151	0.000497	CcSEcCtD
Aripiprazole—Loss of consciousness—Docetaxel—melanoma	0.000151	0.000496	CcSEcCtD
Aripiprazole—Cough—Docetaxel—melanoma	0.00015	0.000492	CcSEcCtD
Aripiprazole—Diarrhoea—Carmustine—melanoma	0.000149	0.00049	CcSEcCtD
Aripiprazole—Pruritus—Temozolomide—melanoma	0.000149	0.00049	CcSEcCtD
Aripiprazole—Convulsion—Docetaxel—melanoma	0.000149	0.000489	CcSEcCtD
Aripiprazole—Nausea—Bleomycin—melanoma	0.000148	0.000487	CcSEcCtD
Aripiprazole—Hypertension—Docetaxel—melanoma	0.000148	0.000487	CcSEcCtD
Aripiprazole—Vomiting—Dactinomycin—melanoma	0.000148	0.000487	CcSEcCtD
Aripiprazole—Rash—Dactinomycin—melanoma	0.000147	0.000483	CcSEcCtD
Aripiprazole—Arthralgia—Docetaxel—melanoma	0.000146	0.00048	CcSEcCtD
Aripiprazole—Myalgia—Docetaxel—melanoma	0.000146	0.00048	CcSEcCtD
Aripiprazole—Chest pain—Docetaxel—melanoma	0.000146	0.00048	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000145	0.000477	CcSEcCtD
Aripiprazole—Dizziness—Carmustine—melanoma	0.000144	0.000474	CcSEcCtD
Aripiprazole—Diarrhoea—Temozolomide—melanoma	0.000144	0.000474	CcSEcCtD
Aripiprazole—Dry mouth—Docetaxel—melanoma	0.000143	0.00047	CcSEcCtD
Aripiprazole—Confusional state—Docetaxel—melanoma	0.000141	0.000464	CcSEcCtD
Aripiprazole—Anaphylactic shock—Docetaxel—melanoma	0.00014	0.00046	CcSEcCtD
Aripiprazole—Oedema—Docetaxel—melanoma	0.00014	0.00046	CcSEcCtD
Aripiprazole—Dizziness—Temozolomide—melanoma	0.000139	0.000458	CcSEcCtD
Aripiprazole—Infection—Docetaxel—melanoma	0.000139	0.000457	CcSEcCtD
Aripiprazole—Vomiting—Carmustine—melanoma	0.000139	0.000455	CcSEcCtD
Aripiprazole—Nausea—Dactinomycin—melanoma	0.000138	0.000455	CcSEcCtD
Aripiprazole—Shock—Docetaxel—melanoma	0.000138	0.000453	CcSEcCtD
Aripiprazole—Rash—Carmustine—melanoma	0.000138	0.000452	CcSEcCtD
Aripiprazole—Nervous system disorder—Docetaxel—melanoma	0.000138	0.000451	CcSEcCtD
Aripiprazole—Dermatitis—Carmustine—melanoma	0.000137	0.000451	CcSEcCtD
Aripiprazole—Thrombocytopenia—Docetaxel—melanoma	0.000137	0.000451	CcSEcCtD
Aripiprazole—Tachycardia—Docetaxel—melanoma	0.000137	0.000449	CcSEcCtD
Aripiprazole—Headache—Carmustine—melanoma	0.000137	0.000449	CcSEcCtD
Aripiprazole—ABCB1—lymph node—melanoma	0.000137	0.00147	CbGeAlD
Aripiprazole—Skin disorder—Docetaxel—melanoma	0.000136	0.000447	CcSEcCtD
Aripiprazole—Vomiting—Temozolomide—melanoma	0.000134	0.00044	CcSEcCtD
Aripiprazole—Anorexia—Docetaxel—melanoma	0.000134	0.000439	CcSEcCtD
Aripiprazole—Rash—Temozolomide—melanoma	0.000133	0.000436	CcSEcCtD
Aripiprazole—Dermatitis—Temozolomide—melanoma	0.000133	0.000436	CcSEcCtD
Aripiprazole—Headache—Temozolomide—melanoma	0.000132	0.000434	CcSEcCtD
Aripiprazole—Hypotension—Docetaxel—melanoma	0.000131	0.00043	CcSEcCtD
Aripiprazole—Nausea—Carmustine—melanoma	0.00013	0.000425	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Docetaxel—melanoma	0.000128	0.000419	CcSEcCtD
Aripiprazole—Insomnia—Docetaxel—melanoma	0.000127	0.000416	CcSEcCtD
Aripiprazole—Paraesthesia—Docetaxel—melanoma	0.000126	0.000413	CcSEcCtD
Aripiprazole—Nausea—Temozolomide—melanoma	0.000125	0.000411	CcSEcCtD
Aripiprazole—Dyspnoea—Docetaxel—melanoma	0.000125	0.00041	CcSEcCtD
Aripiprazole—Somnolence—Docetaxel—melanoma	0.000125	0.000409	CcSEcCtD
Aripiprazole—Dyspepsia—Docetaxel—melanoma	0.000123	0.000405	CcSEcCtD
Aripiprazole—Decreased appetite—Docetaxel—melanoma	0.000122	0.0004	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Docetaxel—melanoma	0.000121	0.000397	CcSEcCtD
Aripiprazole—Fatigue—Docetaxel—melanoma	0.000121	0.000397	CcSEcCtD
Aripiprazole—Pain—Docetaxel—melanoma	0.00012	0.000394	CcSEcCtD
Aripiprazole—Constipation—Docetaxel—melanoma	0.00012	0.000394	CcSEcCtD
Aripiprazole—Feeling abnormal—Docetaxel—melanoma	0.000116	0.000379	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Docetaxel—melanoma	0.000115	0.000376	CcSEcCtD
Aripiprazole—Abdominal pain—Docetaxel—melanoma	0.000111	0.000364	CcSEcCtD
Aripiprazole—Body temperature increased—Docetaxel—melanoma	0.000111	0.000364	CcSEcCtD
Aripiprazole—Hypersensitivity—Docetaxel—melanoma	0.000103	0.000339	CcSEcCtD
Aripiprazole—Asthenia—Docetaxel—melanoma	0.000101	0.00033	CcSEcCtD
Aripiprazole—Pruritus—Docetaxel—melanoma	9.92e-05	0.000326	CcSEcCtD
Aripiprazole—Diarrhoea—Docetaxel—melanoma	9.59e-05	0.000315	CcSEcCtD
Aripiprazole—Dizziness—Docetaxel—melanoma	9.27e-05	0.000304	CcSEcCtD
Aripiprazole—Vomiting—Docetaxel—melanoma	8.92e-05	0.000293	CcSEcCtD
Aripiprazole—Rash—Docetaxel—melanoma	8.84e-05	0.00029	CcSEcCtD
Aripiprazole—Dermatitis—Docetaxel—melanoma	8.83e-05	0.00029	CcSEcCtD
Aripiprazole—Headache—Docetaxel—melanoma	8.79e-05	0.000288	CcSEcCtD
Aripiprazole—Nausea—Docetaxel—melanoma	8.33e-05	0.000273	CcSEcCtD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—melanoma	3.23e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.22e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK3—melanoma	3.22e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK1—melanoma	3.22e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—melanoma	3.22e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NRAS—melanoma	3.22e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PTEN—melanoma	3.22e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CDKN1A—melanoma	3.21e-06	1.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PTEN—melanoma	3.21e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—melanoma	3.2e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NFKB1—melanoma	3.2e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—melanoma	3.2e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HRAS—melanoma	3.2e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—melanoma	3.2e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—melanoma	3.2e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK1—melanoma	3.19e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—melanoma	3.19e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NFKB1—melanoma	3.19e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—melanoma	3.19e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—melanoma	3.19e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—melanoma	3.19e-06	1.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCB1—melanoma	3.18e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—melanoma	3.18e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—melanoma	3.18e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—melanoma	3.17e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—melanoma	3.17e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—melanoma	3.17e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—melanoma	3.16e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HRAS—melanoma	3.15e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—melanoma	3.15e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—melanoma	3.15e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—melanoma	3.14e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK3—melanoma	3.13e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—melanoma	3.13e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—melanoma	3.13e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—melanoma	3.11e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—melanoma	3.11e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—melanoma	3.1e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—melanoma	3.09e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK3—melanoma	3.08e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CD—melanoma	3.08e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK1—melanoma	3.08e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—melanoma	3.08e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—melanoma	3.07e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK1—melanoma	3.07e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—melanoma	3.07e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—melanoma	3.06e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.06e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HRAS—melanoma	3.05e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—melanoma	3.05e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—KRAS—melanoma	3.04e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—melanoma	3.04e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HRAS—melanoma	3.02e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—melanoma	3.02e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—KRAS—melanoma	3.02e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—melanoma	3.01e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—melanoma	3.01e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—melanoma	3e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—melanoma	3e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CDKN1A—melanoma	2.99e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK1—melanoma	2.98e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—melanoma	2.98e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PTEN—melanoma	2.98e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—melanoma	2.98e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NRAS—melanoma	2.97e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—melanoma	2.97e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NFKB1—melanoma	2.97e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—melanoma	2.96e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—melanoma	2.95e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—melanoma	2.95e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—melanoma	2.95e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—melanoma	2.94e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.94e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—melanoma	2.93e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—melanoma	2.93e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—melanoma	2.93e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—melanoma	2.93e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PRKCA—melanoma	2.93e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—melanoma	2.92e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NRAS—melanoma	2.92e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—melanoma	2.92e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NRAS—melanoma	2.92e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—melanoma	2.91e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—KRAS—melanoma	2.91e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—melanoma	2.91e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NRAS—melanoma	2.91e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—melanoma	2.9e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—melanoma	2.9e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ERCC2—melanoma	2.9e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NRAS—melanoma	2.9e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—melanoma	2.9e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—KRAS—melanoma	2.9e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—melanoma	2.89e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HRAS—melanoma	2.88e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—melanoma	2.88e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NRAS—melanoma	2.87e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—melanoma	2.87e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—melanoma	2.87e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NRAS—melanoma	2.86e-06	1.06e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CB—melanoma	2.85e-06	1.06e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK3—melanoma	2.84e-06	1.06e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HRAS—melanoma	2.84e-06	1.06e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—melanoma	2.83e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—melanoma	2.82e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—KRAS—melanoma	2.82e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK3—melanoma	2.8e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.8e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK3—melanoma	2.79e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—melanoma	2.78e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK3—melanoma	2.78e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK3—melanoma	2.77e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—KRAS—melanoma	2.77e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—melanoma	2.77e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—melanoma	2.77e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—melanoma	2.75e-06	1.02e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK3—melanoma	2.75e-06	1.02e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.74e-06	1.02e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—melanoma	2.74e-06	1.02e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—melanoma	2.72e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—melanoma	2.72e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—melanoma	2.72e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—melanoma	2.71e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK1—melanoma	2.71e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—melanoma	2.71e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—melanoma	2.71e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—melanoma	2.7e-06	1e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—melanoma	2.69e-06	1e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—melanoma	2.69e-06	1e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CB—melanoma	2.69e-06	9.99e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—melanoma	2.68e-06	9.97e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—melanoma	2.67e-06	9.95e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—melanoma	2.67e-06	9.94e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—melanoma	2.67e-06	9.92e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—melanoma	2.67e-06	9.91e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—melanoma	2.66e-06	9.91e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK1—melanoma	2.66e-06	9.9e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—melanoma	2.66e-06	9.9e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—melanoma	2.66e-06	9.9e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.66e-06	9.89e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NRAS—melanoma	2.66e-06	9.89e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK1—melanoma	2.66e-06	9.88e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—melanoma	2.66e-06	9.88e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK1—melanoma	2.65e-06	9.85e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—melanoma	2.65e-06	9.85e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK1—melanoma	2.64e-06	9.82e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—melanoma	2.64e-06	9.82e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK1—melanoma	2.61e-06	9.72e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—melanoma	2.61e-06	9.72e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.61e-06	9.7e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—melanoma	2.61e-06	9.69e-06	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—melanoma	2.6e-06	9.68e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—melanoma	2.59e-06	9.62e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—melanoma	2.59e-06	9.62e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HRAS—melanoma	2.59e-06	9.62e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—melanoma	2.57e-06	9.57e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HRAS—melanoma	2.56e-06	9.53e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—KRAS—melanoma	2.56e-06	9.51e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.55e-06	9.47e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.55e-06	9.47e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—melanoma	2.54e-06	9.45e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—melanoma	2.53e-06	9.4e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—KRAS—melanoma	2.52e-06	9.35e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—melanoma	2.51e-06	9.35e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—KRAS—melanoma	2.51e-06	9.33e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—melanoma	2.51e-06	9.32e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—melanoma	2.5e-06	9.31e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—KRAS—melanoma	2.5e-06	9.3e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—KRAS—melanoma	2.49e-06	9.27e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—melanoma	2.48e-06	9.21e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—melanoma	2.48e-06	9.21e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HRAS—melanoma	2.47e-06	9.2e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—KRAS—melanoma	2.47e-06	9.18e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTEN—melanoma	2.46e-06	9.16e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—melanoma	2.46e-06	9.16e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—KRAS—melanoma	2.46e-06	9.16e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HRAS—melanoma	2.46e-06	9.15e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—melanoma	2.45e-06	9.12e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.42e-06	9.01e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—melanoma	2.42e-06	9.01e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HRAS—melanoma	2.39e-06	8.9e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—melanoma	2.37e-06	8.81e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HRAS—melanoma	2.36e-06	8.76e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—melanoma	2.36e-06	8.76e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—melanoma	2.35e-06	8.73e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTEN—melanoma	2.32e-06	8.64e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.31e-06	8.59e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—melanoma	2.31e-06	8.57e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—melanoma	2.3e-06	8.57e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.3e-06	8.55e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CG—melanoma	2.29e-06	8.53e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—melanoma	2.29e-06	8.52e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.29e-06	8.52e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—KRAS—melanoma	2.29e-06	8.51e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—melanoma	2.28e-06	8.49e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—melanoma	2.27e-06	8.45e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.27e-06	8.44e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—melanoma	2.26e-06	8.42e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.26e-06	8.41e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—melanoma	2.26e-06	8.39e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—melanoma	2.24e-06	8.32e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—melanoma	2.24e-06	8.31e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—melanoma	2.23e-06	8.29e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—melanoma	2.22e-06	8.27e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—melanoma	2.22e-06	8.24e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—melanoma	2.21e-06	8.23e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—melanoma	2.19e-06	8.16e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—melanoma	2.19e-06	8.14e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—melanoma	2.18e-06	8.13e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—melanoma	2.17e-06	8.08e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HRAS—melanoma	2.17e-06	8.08e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—HRAS—melanoma	2.14e-06	7.95e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HRAS—melanoma	2.13e-06	7.93e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HRAS—melanoma	2.13e-06	7.91e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HRAS—melanoma	2.12e-06	7.88e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—melanoma	2.11e-06	7.86e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.1e-06	7.82e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HRAS—melanoma	2.1e-06	7.81e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HRAS—melanoma	2.09e-06	7.78e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—melanoma	2.08e-06	7.74e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—melanoma	2.08e-06	7.73e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—melanoma	2.05e-06	7.64e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—melanoma	2.05e-06	7.61e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—melanoma	2.04e-06	7.59e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—melanoma	2.04e-06	7.57e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—melanoma	2.03e-06	7.56e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—melanoma	2.03e-06	7.54e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CD—melanoma	2.02e-06	7.5e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—melanoma	2.01e-06	7.47e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—melanoma	2e-06	7.45e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—melanoma	1.99e-06	7.4e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HRAS—melanoma	1.94e-06	7.23e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—melanoma	1.92e-06	7.13e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—melanoma	1.89e-06	7.02e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—melanoma	1.88e-06	7e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—melanoma	1.88e-06	7e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—melanoma	1.88e-06	6.98e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—melanoma	1.87e-06	6.96e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—melanoma	1.86e-06	6.92e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—melanoma	1.85e-06	6.89e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—melanoma	1.85e-06	6.87e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CB—melanoma	1.76e-06	6.53e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—melanoma	1.74e-06	6.47e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—melanoma	1.74e-06	6.46e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—melanoma	1.72e-06	6.39e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—melanoma	1.64e-06	6.09e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTEN—melanoma	1.52e-06	5.65e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—melanoma	1.42e-06	5.28e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—melanoma	1.34e-06	4.98e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—melanoma	1.07e-06	3.98e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—melanoma	8.75e-07	3.25e-06	CbGpPWpGaD
